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Heterologously expressed acyl carrier protein domain of rat fatty 
acid synthase functions in EscherMA co/i fatty acid synthase 
and Streptomyces coelicolor polyketide synthase systems 
Susanne Tropf ‘I*, W Peter Revill*, Maureen J Bibb*, David A Hopwood* 
and Michael Schweizerl 
Introduction: Fatty acid synthases (FASs) catalyze the de nova biosynthesis of 
long-chain saturated fatty acids by a process common to eubacteria and 
eukaryotes, using either a set of monofunctional proteins (Type II FAS) or a 
polypeptide containing several catalytic functions (Type I FAS). To compare the 
features of a Type I domain with its Type II counterpart we expressed and 
characterized an acyl carrier protein (ACP) domain of the Type I rat FAS. 
Results: An ACP domain of rat FAS was defined that allows expression of a 
small percentage of active holo-ACP both in Escherichia co/i, increasing fivefold 
upon co-expression with an E. co/i holo-ACP synthase, and in Sfreptomyces 
coelicolor. The rat ACP domain functions with some components of the E. co/i 
FAS, and can replace the actinorhodin polyketide synthase (PKS) ACP in 
S. coe/ico/orA3(2). Purification of the rat ACP domain from E. co/i resulted in loss 
of its functionality. Purified apo-ACP could be converted to its holo-form upon 
incubation with purified E. co/i holo-ACP synthase in vitro, however, suggesting 
that the loss of functionality was not due to a conformational change. 
Conclusions: Functionality of the recombinant rat ACP was shown in distantly 
related and diverse enzyme systems, suggesting that Type I and Type II ACPs 
have a similar conformation. A procedure was described that might permit the 
production of rat FAS holo-ACP for structural and further biochemical 
characterization. 
Introduction 
The vertebrate fatty acid s)-nthase (FAS, EC 2.3.1.85) cat- 
ulpzes the tit NUCO biosynthesis of long-chain saturated 
fatty acids from acetyl-GA, malonyl-CoA and NADPH in 
an iterati1.e process involving seven catalytic c)-clcs. A 
single reaction cycle requires seven functions that are 
integrated into a large polypeptide, each forming a distinct 
domain within this Type I FAS system [1,2]. In contrast, 
the Type II FAS, such as that found in Es&-klll(l (u/i and 
plant plastids. consists of several discrete monofunctional 
polypeptides, each of which bears reasonable secluencc 
similarity to the corresponding domain of the ‘I’)-pe I FAS 
[3,4]. Thus. the ‘l’);pe I and Type II FASs appear to be 
structurally and mechanistically related, possibly reflect- 
ing an early gene fusion that gave rise to the Type I FM 
found in ~ertebratcs. Bye are interested in exploring the 
relatedness between the domains of the Type I rat FXS 
and the corresponding monofunctional polvpeptides of 
the Type II FASs. 
The active \,ertebrate FAS is a dimer with two identical 
subunits orientated in a head-to-tail fashion to form two 
catalytic centers, each center being made LIP of functions 
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from both subunits [ 1,5.6]. Initiation of fatty acid biosyn- 
thesis requires the malonyl/acct)-1 transferase (hi/AT)-cat- 
alyed loading of substrates onto specific sulfhydryl 
groups in the FAS complex. An acetyl residue from 
acetyl-Co.4 is transferred onto the cysteine sulfhydryl 
group in the active center of the P-ketoacylsynthase (KS). 
lia the acvl carrier protein (ACP), and ;1 malonyl residue 
is transferred to the sulf’hpdryl group of the -I’-phos- 
phopantetheine prosthetic group of the ACP. KS then 
catalyzes a decarboxylative condensation to yield P-ketoa- 
cyl-,4CP. The resulting P-ketogroup is reduced to a meth- 
ylene functionality by the action of a ketoreductase (I(K). 
a dehpdratase (DH) and an enoylreductase (EK) prior to 
transfer back to the KS, and condensation with malonyl- 
ACP. During the reduction sequence. all the intermedi- 
ates remain bound to the sulfhydr!-l group of the 
3’-phosphopantetheine residue attached to the XCP. 
Once a chain length of 16 carbon atoms is reached. the 
thioesterase (TE) releases free palmitic acid from the 
complex [ 1,2]. These reactions are basically the stimc in 
al1 organisms regardless of the structural organization of 
the F.4S complex. In k’. <o/i. however, there is no TE and 
acyl chains are directly transferred from ac~l-ACP to 
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Rat fatty acid synthase. (a) Linear domain 
map of rat FAS showing the active site 
residues. KS, P-ketoacylsynthase; M/AT, 
malonyl/acetyl transferase; DH, dehydratase; 
ER, enoylreductase; KR, ketoreductase; ACP, 
acyl carrier protein; TE, thioesterase. 
(b) Extents of the two ACP constructs. DNA 
sequences encoding rat ACP were amplified 
by PCR using pcRFAS601 C [54] as the 
template and primers l-4 as described in the 
Materials and methods section. 
ACP(aa2131-2194) corresponds to exon 38, 
and ACP(aa2114-2202) corresponds to the 
extended ACP domain. The red triangles 
indicate the expected attachment site for the 
4’.phosphopantetheine residue. 
membrane phospholipids. Furthermore, the E. coli FAS 
system contains more than one protein for some of the 
functions; for example, there are three known KS 
enzymes with different specificity for chain length and 
degree of saturation of the growing carbon chain [4]. 
Within the Type I FASs, the individual functions are cat- 
alyzed by distinct domains, which are thought to be sepa- 
rated by short linker regions of about 15 amino acids [Z]. A 
linear domain map of the vertebrate FAS was first estab- 
lished by isolation of functional fragments after partial 
proteolysis of FAS [7-lo]. The biochemical map was 
further confirmed after cloning and sequencing of cDNAs 
and genes for FAS from rat, chicken and man, which 
allowed comparison to known genes of Type II FASs 
[l l-151. Biochemical and molecular biological approaches 
were used to map the domain boundaries within rat FAS 
[ 161 (Figure la). The catalytic independence of some of 
the domains of vertebrate FAS was shown by isolation of 
functional domains after limited proteolysis [9,17] and by 
heterologous expression, in E. co& of the TE domain 
[ 18,191 and, more recently, the M/AT and the DH 
domains [ZO,Zl] as individual proteins. 
Functional analysis and sequence comparisons have 
shown that the Type I and Type II FASs are closely 
related [Z]. It is, therefore, interesting to ask whether an 
independently expressed Type I domain would retain its 
partial activity and/or whether it could interact with the 
components of a Type II system; and whether the three- 
dimensional structure of such a domain would resemble 
that of the independent Type II protein. A first step 
towards this understanding was the definition of a func- 
tional domain, its heterologous expression and the func- 
tional analysis of the resulting protein. 
We investigated the ACP domain of rat FAS. Type II 
ACPs, such as those found in E. coli, are small acidic pro- 
teins of about 80-100 amino acids that are well charac- 
terised not only biochemically but also at the level of their 
tertiary structures [22-2X]. The active holo-ACPs have a 
4’-phosphopantetheine moiety attached to a specific serine 
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residue in a well-conserved region; this reaction is catalyzed 
by the holo-ACP synthase [29]. We show here that it is pos- 
sible to express an ACP domain of rat FAS in E. co/i, that a 
small percentage is post-translationally modified, and that 
the rat holo-ACP is functional within the E. co/i FAS 
system. The rat ACP domain was purified after overexpres- 
sion in E. coli, and was post-translationally modified by the 
overexpressed E. coli holo-ACP synthase specific for the 
FAS ACP i;ll aitro. 
We have also explored the possibility of expressing the rat 
ACP in Streptomyces coelicolor to assess its functionality 
within a Type II polyketide synthase (PKS) system. The 
key reaction in polyketide biosynthesis catalyzed by the 
PKS is, as in fatty acid biosynthesis, the decarboxylative 
condensation of carboxylic acids. In contrast to fatty acid 
biosynthesis, however, the start of a new condensation 
round does not require reduction of the P-ketogroup. These 
reactions can be fully or partially omitted in polyketide 
biosynthesis, a factor contributing to the variety of struc- 
tures found among polyketides. Characterisation of the 
enzymes involved in polyketide biosynthesis and the 
cloning of various PKS genes have revealed that the 
enzymes not only are functionally similar to those of fatty 
acid biosynthesis but also have a reasonable degree of struc- 
tural similarity, and probably share a common evolutionary 
origin. As with FAS, different structural organisations of the 
enzyme systems are distinguished: PKSs consisting of a set 
of monofunctional proteins (Type II), such as those found 
in S. <oelicoolor, and multifunctional Type I PKSs, which are 
either of modular construction or the iterative type like ver- 
tebrate FAS [30-321. We show that the rat FAS ACP 
domain can functionally replace, albeit with low efficiency, 
the ACP of a Type II PKS in S. roehcolor. 
Results and discussion 
Definition of a domain 
The attachment site for the 4’-phosphopantetheine pros- 
thetic group in rat FAS had been identified previously as 
SerZlSl [12]. This amino acid is encoded within exon 38, 
which corresponds to amino acids 2132 to 2194, of the rat 
FAS gene [12]. It has been suggested that multienzyme 
proteins of vertebrates, such as FAS, might have evolved 
by recombination within certain introns at or near the 
boundaries of monofunctional ‘progenitor-genes’ to give 
multidomain gene-fusion products [33]. From sequence 
comparisons with monofunctional (Type II) ACPs and 
those of other multifunctional FASs, and results from 
limited proteolytic digestion of rat FAS, it was proposed 
that the boundaries of the ACP domain lie approximately 
between amino acids 2114 and 2190, which corresponds, 
more or less, to a protein fragment encoded by exon 38 with 
an extension at its amino terminus [16]. Two approaches 
were taken to define a possible functional domain. First, a 
protein encoded strictly by exon 38 was expressed. In the 
second approach, a protein was expressed that corresponds 
to the fragment released by limited proteolysis of multi- 
functional FAS and has, compared to the exon 38-encoded 
protein, an amino-terminal extension of 17 amino acids and 
an additional eight amino acids at the carboxyl terminus. 
To create a plasmid for expression of a protein encoded by 
exon 38 of rat FAS, a segment of DNA coding for amino 
acids 2131 to 2194 was constructed as described in the 
Materials and methods section. This plasmid was desig- 
nated pETlSb-ACP(aa2131-2194). It codes for a protein of 
65 amino-acid residues with a calculated M, of 7233.2 Da, 
with the start methionine lying 21 amino acids upstream of 
Ser2151. The calculated higher isoelectric point and the 
overall net charge show that this protein is much less acidic 
and less charged than the E. coli ACP (Table 1). Attempts 
to express the rat ACP(aa2131-2194) did not result in 
induction of any additional protein when compared to the 
pET15b vector control as judged by SERVA Blue R stain- 
ing of a 20% native polyacrylamide (PA) gel (Figure 2a, 
lanes 1 and 2). Further attempts to improve the level of 
expression by incubation of the cultures for different times 
after induction, or by inducing at different temperatures, 
were not successful. Attempts at detection of an active ACP 
domain using the highly sensitive malonyl-CoA:ACP 
transacylase assay (see below) did indicate that occasionally 
some low level of induced ACP product was present, but 
the level varied from one induction to the next. 
The second expression clone, pETlSb-ACP(aa2114-2202), 
was constructed as described in the Materials and methods 
section. Similar to the clone for the exon 38-encoded 
protein, the second clone encodes a slightly acidic and 
charged protein, but contains 90 amino acids with a calcu- 
lated IM, 9817.2 Da, in which the initial methionine is 
located 38 amino acids upstream of serine 2151 (Table 1). 
Expression from this plasmid led to induction of a soluble 
protein corresponding to approximately 10% of total E. coli 
extract, which could be visualized using 20% native poly- 
acrylamide gel electrophoresis (PAGE; Figure 2a, lane 3). 
Although the codon usage of the first clone, comprising 
exon 38 only, was unaltered, seven of the first ten codons 
agree with an optimal codon usage in E. coli (codons at posi- 
tion 5, 7 and 8 are suboptimal [34]), so overall expression 
Table 1 
. Some physical characteristics of the rat ACP domains 
compared to those of the E. coli ACP. 
Rat ACP Rat ACP 
(aa2131-2194) (aa 14-2202) f. co/;ACP 
Amino acids (+ Met) 65 90 78 
Molecular mass (Da) 7233.2 9817.2 8639.5 
PI 4.59 5.21 3.81 
Net charge (pH 7.0) -4 -3 -14 
Calculations were done for proteins with the start methionine present 
using algorithms from the UWGCG programme [65]. 
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Figure 2 
(a) 
1 Expression of rat FAS ACP domains. Soluble 
fractions of each cell extract were analyzed on 
20% native polyacrylamide gels. 20 pg of 
protein was loaded per lane. The gels were 
stained with SERVA Blue R. (a) Expression of 
rat ACP domain in E. co// BL21 (DE3) cells 
transformed with: pETl5b, lane 1; 
pET1 Sb-ACP(aa2131-2194), lane 2; 
pET1 Sb-ACP(aa2114-2202), lane 3; and 
pETl5b-ACP(aa2114-2202)~acpS, lane 4. 
(b) Expression of rat ACP In S. coe/ico/orA3(2) 
CH999 (lane 1 is CH999 alone) transformed 
with: pRM5-rat ACP, lane 3; and pRM5, 
lane 2. 
- Rat ACP 
(aa 14-2202) 
(b) 
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(aa 14-2202) 
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should not be affected. This would suggest that the addi- 
tional amino acids, especially at the amino terminus, in the 
90 amino acid .4CP(aa211;C2202) might be important for 
folding to form a stable protein. Amino-terminal sequenc- 
ing of the first eight amino acids of ACP(aa211+2202) 
sho\ved the expected sequence for approximately one third 
of the induced protein, the remainder having had the 
amino-terminal methionine removed (consistent with the 
predictions of Hire1 UC//. [%I). ACP(aa21 l-k-2202) MX t~scd 
for all further studies. 
Evidence for post-translational modification of rat 
ACP(aa2114-2202) upon expression in E. co/i 
Functionality of the rat ACP(aaZ114-2202) domain would 
require correct l”)st-t’“nslational modification by addition 
of A’-phosphopantetheine, transferred from cocnzyme A 
(k4) to the inacti\,e ape-ACP to form the acti1.e holo- 
ACP. catalyzed by one of the K. 1,0/i holo-ACP s!-nthases 
[29]. Holo-A(IP would then be the substrate for the 
malon)-I-<:or\:X<:P trdnsaqilase (YIC.47’). which transfers 
the malonyl residue from its CoL4 ester onto holo-ACP. 
The hICAT reaction n-as used to test the extent of phos- 
phopantethein);lation of heterologously expressed rat 
ACP. :\ddition of [2-‘-‘C]malon);l-Coi-\ to E. m/i crude cell 
extract in which the rat ,4CP was expressed resulted in 
labeling of an additional protein (Figure Ai, tanc 2) in 
comparison to the reaction \vith E. r-o/i BIZl(IIE3)/ 
pE’l’1 Sb extract (Figure 3a, lane 1). ‘I’his labcted band co- 
migrates with the induced .ACP(aa2113-2202), identified 
by (Aomassie Blue staining. under the same gel cond- 
tions (data not shou n), No further increase in intensit)- of 
the rat I~(:-maion\-I-A<:P wx obtained by prolonging the 
assa); incubation time, by addition of EI. cc//i DHSa crude 
extract to attcr the ratio of \ICXT:ACP or by increasing 
the amount of [2-‘1C]malonyl-CoA added. The level of 
the I%-maIon\-I-ACP signal was directly proportional to 
the degree of expression of the rat ACP in the extract, 
ho\ve\er (data not shown). ‘This suggests that. under the 
induction conditions used, the availability of rat holo-A(:P 
is a limiting factor in the assa). Assuming that the 15;. w/i 
ACP accounts for up to 0.25% of the total I?. w/i protein 
[-I], and 100% of the .k’:. u/i ‘4CP is present in its holo-form 
[Xl, comparison of the intensities of the labclcd hands 
suggests that about 1% of the totat induced rat A(3 is in 
its holo-form. .Attempts to increase the proportion of rat 
holo-ACP b); induction at a to\ver temperattlrc (Z”(1), or 
by incubation for an extended time after induction (up to 
1-l h at 25YI and 37”C), as prcviouslv described for some 
,st/.qtoiN)‘M.c ACP [37.38], wcrc unwcccssful. 
The cu;nS gene encodes one of three phosl’hop”ntethein~l 
trdnsferases in 1”;. c.v/i required for activation of .4(X’-like 
proteins [39]: the gene product. holo-ACP synthasc 
(ACPS), is required for i/r z,if~~ modification of the F-AS 
ACP of R. u//i. Previous studies had shokvn that by increas- 
ing the levzl of ~cp.)’ expression in R. m/i, producing large 
quantities of PKS ACP. a dramatic incrcasc in the amount 
of holo-ACP formed \vas obsewed [3X]. 1 Jsing a similar 
method, \ve engineered the rat F.4S expression plasmid 
pE’TlSb--XCP(aaZllG2202) so that Nqs \vas ctoned 
downstream of the rat XCP gene in the same transcrip- 
tional unit to create plasmid pETlSb-A(:P(aaZl 1A- 
2202)~n+S. Results from induction of the ptasmid :‘i<:P- 
u+S in I?‘. co/i arc she\\ n in Figure 21, lane 4. ‘T‘hc \I(XT 
assay performed with extracts from induced cells of ti:. w/i 
BI,21(I>E3)-pE’Tl.~b-.4\(:P(~~~~21 lL22O?)-q9~S showed ;I 
fivefold stronger labeling of the A(:P udduct (Figure .?a, 
lane 3). For all further experiments described belo\v, 
extracts were prepared from cells co-cxprcssing the rat 
ACP gene and the k;. Eli 0+S. 
The results from co-expression of ut ACP and 1;. c.Oli AU’S 
showed that the hoto-ACP synthase is capable of transfer- 
ring the A’-phosphopantetheine onto the heterologoust~ 
expressed rat ,4CP. The increase in the amount of rat holo- 
ACP generated when co-expressed with the E. w/i u+Y \vas 
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Figure 3 
Loading of the [2-‘4C]malonyl residue from its 
CoA ester onto the rat ACP(aa21 14-2202). 
The panels show autoradiographs of assay 
incubations after separation using 20% native 
PAGE and transfer to PVDF membrane. The 
MCAT assay relies on the presence of 
endogenous FAS malonyl:CoA-ACP 
transacylase in the crude cell extract. 
(a) MCAT assay in E. co/i crude cell extracts 
prepared from induced cultures of E. co/i 
BL21 (DE3) transformed with: pETl5b, lane 1; 
pETl5b-ACP(aa2114-2202, lane 2; and 
pETl5b-ACP(aa2114-2202)-a@, lane 3. 
(b) MCAT assay in S. coe/ico/orA3(2) CH999 
crude cell extracts: CH999 alone, lane 1 ; 
CH999/pRM5, lane 2; and CH999/pRM5-rat 
ACP, lane 3. M-ACP, malonyl-ACP; act, 
actinorhodin PKS. 
‘( a) 1 2 3 
Rat 
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not as great as with the PKS ACP [3X], however, for which 
up to 90% holo-form was obtained. A possible reason for the 
inefficient modification in the E. &i is that the rat 
ACP(aa2114-2202) is a poor substrate for the E. co/i ACPS. 
Gehring era/. [39] observed a correlation between high net 
charge of the ACP and efficiency as a substrate for the 
ACPS protein. The rat ACP(aa21 lG%?O2) has an o\,erall 
lower net charge, a significantly higher isoelectric point, and 
only 29% amino-acid identity with the E. roli ACP. so it 
may well be that differences in the conformation of the rdt 
ACP could make it ;I poor substrate for the ACPS protein. 
Previously. a Ru~i/,!u.s .sz&i/is peptidyl carrier protein (P(:P) 
domain of a multifunctional peptide synthase, which 
exhibits a similar high isoelectric point and a similar lo\\ net 
charge to the rat ACP(aaZll-L-2202) (Table l), \I’BS shown 
to be a better substrate for the E. di EntD protein. the 
phosphopantetheine transferase specific for modification of 
the multifunctional EntF protein [40,11] of E. /-o/i than for 
ACPS. One might therefore speculate that the E. w/i XPS 
is also not the best enzyme for modification of rat 
ACP(aa2114-2202). Reports of the expression in E. di of 
the complete human FAS as a maltose-binding protein- 
fusion [42], or the ACP-TE fusion of chicken FAS [18], 
have sho\vn that the heterologous proteins are 1005% and 
about 60% I-‘hosl-‘hol’antethein~l~lted, respecti\+: this 
might mean that cxprcssion of an ACE’ domain in the 
context of surrounding domains allo\vs more efficient modi- 
fication in E. <o/i. either by the E. di ACPS or by one of 
the other holo-ACP synthases (such as EntD). 
Functionality of the rat ACP in diverse enzyme systems 
Functionality within the E. coli Type II FAS system 
P-Ketoacylsynthase (KS) III of E. roll specificall>- cat- 
alyzes the initial condensation of fatty acid biosynthe- 
sis, between acetyl-CoA and malonyl-ACP, to form 
acetoacetyl-XCP, which is subsequently reduced, in three 
steps, to form butyryl-XCP. KS III can also act as an 
acetyl-Co,\:ACP transaqlase, though this is a relati\~el) 
minor reaction ;N .i+rn compared with the condensation 
reaction [13]. KS I and KS II then catalpse further conden- 
sations to form long-chain fatty acids [-I]. KS I has also 
been sho\\n - at least in .;it/u - to circum\ ent the 
requirement for KS III by decarbox~lation of malonyl- 
ACP to form acetyl-ACP and condensation of acctyl-hCP 
and malonyl-ACP. Post-Beittenmiller f/f a/. [+I] described 
the USC of conformationally sensiti1.e PAGE in the pres- 
ence of 0.5 11 urea to separate short-chain length acyl- 
ACP species. \Ve wxd this system to explore further 
possible interactions bctwcen the rat FXS ACP and other 
components of the E. cali FM system. Figure 4 show the 
results of \wious incuh;ttions. dcscrihcd hclo\~, :inalyzcd 
by 1.5% PA(;E using 0.5 n1 urea and ~lutoradiograph~. 
In comparison to the E. uJi control reactions (no rat ACP 
expressed, data not shown). additional bands \jith higher 
mobilitics wcrc obtained in some of the reactions in which 
the rat ACP \V:IS included. The result of an \l(Z’l‘ assq 
yielding [Z-‘-‘C]m3lonvl-.~CP is sh0v.n in Figure 1, lane 1. 
Incubating E. w/i crude extract with [1-‘-‘(:]acet?l-(:(,A. 
results in faint labeling of the E‘. co/i A(:P (Figure 4. 
lane 2), which is consistent with pre\ ions obscrl-ations of a 
low wetyl-CoA:hCP transacylase activity [13]. :\n e\.cn 
fainter signal. corresponding to rat [1-‘-‘C]acct~l-,~(:I’. was 
only observed when high specific acti\-ity [ 1 -“C]acet)-l- 
(:oA MM used (data not shown). \\‘hen both substrates 
([Z-‘~(:]mLllon);l-CoA and acetyl-Co;\) were used together 
no distinct band corresponding either to rat acctoacet)-l- 
XCP or to E. &i acetoacetyl-ACP could bc seen (Figure 4. 
lane 7). This is consistent with the known instability of 
acetoacetyl-ACP [45]. \Vhen wet!-I-(10.1. ~~~alon~l-CoA, 
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Figure 4 
Lane 1 2 3 4 5 6 7 8 
Ualonyl-CoA I - u LI I I I I 
Acetyl-CoA - I I 
NAD(P)H - - + : : : ” + 
Cerulenin - - + - + - - - 
Rat 
Acyl-ACP - 
M-ACP - 
E. co/i 
M-ACP \ 
A-ACP x 
B-ACP - 
Acyl-ACP ’ 
Chemlstrv & B~olocw 
Formation of acyl-ACP species of the rat ACP domain in E. co/i 
extracts. The assays were as described in the text, and the reaction 
products were analyzed by autoradiography after separation on 15% 
PAGE in the presence of 0.5 M urea and blotting to PVDF membrane. 
substrate, NAD(P)H or inhibitor not added; +, NAD(P)H or inhibitor 
idded; u, addition of unlabeled substrate; I, addition of the i4C-labeled 
substrate; M-ACP, malonyl-ACP; A-ACP, acetyl-ACP; B-ACP, butyryl- 
ACP; acyl-ACP, ACP labeled with intermediate-chain to long-chain 
saturated fatty acids. 
NADH and NADPH were all used in the assay, a band of 
lower mobility was readily visualized, however (Figure 4, 
lanes 4,6). The altered mobility indicates that a new 
product had been formed by the action of one or more of 
the E. co/i KS with the rat ACP; the presence of reducing 
agents allowed reduction of the B-ketoacyl-ACP conden- 
sation product to form a more stable acyl-ACP intermedi- 
ate, which is amenable to analysis using native PAGE. To 
determine with which KS the rat ACP is capable of inter- 
acting, the same reaction was performed in the presence 
of cerulenin. This antibiotic specifically inhibits KS I and 
KS II (but not KS III) by covalently binding to the 
sulfhydryl group of the fatty acyl-binding site of the 
enzyme [3]. When conditions described for lanes 4 and 6 
were used, in the presence of cerulenin (lanes 3,.5), no rat 
ACP species was detected. E. co[i butyryl-ACP was 
detected, however, indicating that the E. co/i KS III was 
functional in this assay, modifying its own E. coli ACP but 
not the rat ACP. Thus, the rat acyl-ACP band seen in the 
absence of cerulenin (lane 4) is presumably the result of 
an interaction with KS I or KS II. When incubations were 
performed using only malonyl-CoA, NADH and NADPH, 
again the band of lower mobility was observed (Figure 4, 
lane 8), consistent with previous observations that KS I 
can decarboxylate malonyl-ACP [3] and initiate fatty acid 
carbon chain assembly, indicating that at least KS I is 
interacting with the rat ACP in z&o. In all of these reac- 
tions, the observed pattern of E. co/i acyl-ACP species 
formed is consistent with what was expected [46], and 
serves as an internal control. It is worth mentioning that 
the acyl-ACP species generated from the rat ACP migrates 
more slowly than the malonyl-ACP, whereas for E. co/i 
ACP the opposite is true (lane 4). 
‘Several groups have described the use not only of coen- 
zyme A but also of substrate analogs or acyl-CoAs by the 
E. co/i holo-ACP synthase (ACPS) [38,39,47]. Using the 
ACPS reaction described below, it was possible to syn- 
thesize rat malonyl-ACP, acetyl-ACP and palmitoyl- 
ACP. IJnder the gel conditions used, these acyl-ACP 
standards co-migrated with the labeled product of the 
MCAT assay (Figure 4, lane l), ACAT assay (lane 2) and 
FAS assay (lane 4) (data not shown); it was not possible 
to distinguish between different long-chain acyl-ACP, 
but the co-migration of palmitoyl-ACP and the ‘acyl’- 
ACP synthesized in the FAS assay (lane 4) confirmed 
that at least butyryl-ACP was formed. 
In E. co/i, free long-chain fatty acids are reintegrated into 
fatty acid metabolism by transfer onto holo-ACP, catalyzed 
by the acyl-ACP synthetase [48]. To test the potential for 
interaction with the rat ACP, acyl-ACP synthetase was 
incubated with crude cell extract of E. co/i BLZl(DE3)/ 
pETlSb-ACP(aaZ114-2202)-acpS and [1-‘“C]palmitic acid 
The reaction products were analyzed by conformationally 
sensitive PAGE in the presence of 2.5 M urea. Under con- 
ditions where the E. co/j [1-i%]palmitoyl-ACP was readily 
detected, no rat [I-‘%]palmitoyl-ACP could be seen (data 
not shown). It is interesting to note that in the complete rat 
FAS (Figure l), the ACP domain would not normally inter- 
act with an acyl-ACP synthetase domain nor a KS III, but 
would be expected to interact with the equivalent KS I, an 
hICAT and the reductases. Structural studies on the rat 
FAS ACP domain might shed light on the features that 
allow this discrimination in E. co/i. 
Functionality of the rat ACP(aa2 114-2202) in a Type II PKS 
The Type II PKS of Streptoqws spp. consists of, amongst 
other components, an ACP, a KS and an additional protein 
called the chain length factor. These three components 
form the minimal PKS. Poiyketides are synthesized by 
condensation of acetyl and malonyl units to form long- 
chain products, which, unlike fatty acids, remain unre- 
duced at most or all B-carbons. A more rigorous test for the 
functionality of the rat ACP domain was its interaction 
with components of such a PKS system. The S. co&ol- 
orA3(2) CH999/pRh15 PKS expression system was devel- 
oped for the construction and expression of recombinant 
PKS [49]. The parental pRM.5 vector encodes the so- 
called ‘minimal PKS’, a ketoreductase, an aromatase and a 
cyclase [49] which together direct synthesis of the dif- 
fusible yellow-brown shunt product aloesaponarin II. 
Expression is performed in S. coe/icolorA3(2) CH999, in 
which the entire chromosomal actinorhodin (art) PKS 
gene cluster has been deleted. 
ACP(aa2114-2202) was cloned in pRM5 precisely replac- 
ing the act ACP gene (actI-ORF3) in a similar manner to 
that described by Revill et al. [.50] for the FAS ACP of 
S. coelicolor itself. The resulting plasmid, pRhlS-rat ACP, 
when introduced into S. coelicolorA3(2) CH999 produced a 
small amount of diffusible yellow-brown pigment charac- 
teristic of aloesaponarin II (approximately 1% of that seen 
for the S. coelicolor CH999/pRM5 control), whereas S. coeli- 
color- CH999 alone did not produce any pigment. The 
nature of the product synthesized was confirmed by extrac- 
tion of the pigment and co-migration with standard aloe- 
saponarin II on TLC plates (Figure 5). To confirm that the 
low amount of pigment production by CH999/pRhl5-rat 
ACP was dependent on the presence of the rat ACP. an 
inactive pRM5-rat ACP derivative was constructed in 
which the attachment site for the prosthetic group 
(Ser2151) of rat ACP had been changed to an alanine 
residue. No pigment production was directed from this 
plasmid in CH999 (data not shown). Structural features 
and/or a low percentage of rat holo-ACP(aaZ11-C2202) 
might account for the inefficient replacement of the ad 
ACP, but it is nevertheless significant that the rat FAS 
ACP domain could function in this system. 
Analysis of the crude protein extract of S. coelicolor CH999/ 
pRMS-rat ACP using Coomassie Blue staining of a 20% 
native polyacrylamide gel showed that the rat ACP 
domain is expressed at a moderately high level (Figure 2b, 
lane 3); this could provide an alternative source for the rat 
ACP domain for future analysis. By way of confirming the 
activity of the rat ACP domain, 5’. coelicol’or/pRM5rat ACP 
extracts were analyzed using the hICAT assay (Figure 3b), 
demonstrating that the rat ACP is post-translationally 
modified in S. coeL’icolor and interacts lvith the host’s 
MCAT (lane 3). 
Our biochemical characterization of the independently 
expressed rat ACP domain has shown that rat ACP(aa2114- 
2202) can interact as a Type II component within struc- 
turally and functionally divergent systems, suggesting a 
conservation in the structural characteristics of a Type I 
ACP domain and Type II FAS and PKS ACP [23-281. 
Purification of the recombinant rat ACP(aa2114-2202) 
domain from E, co/i 
The E. cok strain BLZl(DE3)/pETlSb-ACP(aa2114- 
2202)--acpS was used to produce rat ACP(aa2114-2202). 
From a 500 ml culture of induced bacteria, 1.9 mg of the 
protein was purified in three steps, as described in the 
Materials and methods section, and illustrated in Figure 6. 
Functionality of the purified rat ACP(aa2114-2202) was 
tested in the MCAT assay by addition of E. co/i DHSa cell 
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Figure 5 
-F 
Aloesaponarin II 
-s 
Che mlstr) i&B dogy 
Thin layer chromatography (TLC) analysis of extracts from 
S. coe/ico/orA3(2) CH999, lane 1; CH999/pRM5, lane 2; 
CH999/pRM5-rat ACP, lane 3; authentic aloesaponarin II, lane 4. To 
detect aloesaponarin II produced by CH999/pRM5-rat ACP a highly 
concentrated extract was analyzed. PKS proteins encoded by pRM5 
also produce other compounds, one of which was identified as 
3,8-dihydroxy-1 -methylanthraquinone-2-carboxylic acid [49], and which 
shows no migration in the solvent system used. S, start; F, front. 
extract and [2-11C]malonyl-CoA. No labeling of the rat 
ACP was detected (data not shown). In RlCAT assays 
with fractions obtained after the second purification step 
only a faint labeling of the rat ACP was detectable, 
whereas after the first step, a freeze-thaw extract, strong 
labeling was detectable even after repeated freezing and 
thawing. Further experiments showed that purification by 
other methods (such as simple gel filtration of crude 
extracts. or even just dilution of the crude E. co/i extract), 
resulted in loss of the ability to be labeled by the E. co/i 
hICAT using the [2-11C]malonyl residue. Addition of 
bovine serum albumen (BSA), glycerol or ethylene glycol 
had no stabilizing effect on the rdt ACP(aa211-L2202) in 
diluted E. coli extracts. 
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Purification of the heterologously expressed rat ACP domain (amino 
acids 21 14-2202). Samples of the recombinant ACP protein were 
analyzed by SERVA Blue R staining of a 15% SDS PAGE at different 
stages of a typical purification procedure. Molecular mass standards, 
lane 1 ; extract from cells transformed with pETl5b (20 pg), lane 2; 
freeze-thaw extract of cells transformed with pET1 Sb-ACP(aa2114- 
2202)~acpS (20 pg), lane 3; combined fractions after preparative 20% 
native PAGE (10 wg), lane 4; combined fractions after anion-exchange 
chromatography on MonoQ (10 pg), lane 5. 
Electrospra~- mass spectrometr); (EShlS) of the purified 
protein gave a molecular mass of 9682.43 k 4.20 Da and 
9812.32? 1.3X Da for a second, minor species (Figure 7). 
‘[‘he first molecular mass is in good agreement with the cal- 
culated mass of 9686.07 Da for the apo-ACP(aa2114-2202) 
lacking the amino-terminal methionine, \vhereas the mol- 
ecular mass of the second species corresponds to the apo- 
XCP \vith the methionine still attached to the amino 
terminus. Partial remol-al of the methionine had already 
been shown to occur. by amino-terminal sequencing of 
the ACP (see abo\,e). As expected, no peak corresponding 
to a molecular mass of the holo-ACP(aaZ1 14-2202) \vas 
detected. Possible explanations for this apparent loss of 
activity arc: spontancow oxidation of the sulfhydryl 
grorlp of the ~‘-phosphop”ntetheine prosthetic group; 
spontaneous elimination of the prosthetic group (both 
processes arc known to occur bvith E. CO/~ ACP at higher 
pH \.alues and during prolonged incubation at higher 
tcmper;1tures [22]); or a change in the overall conforma- 
tion of the ACP, \vhich awuld make an interaction with 
the E. c.oli hlC,L\‘I’ impossible. 
In vitro conversion of purified rat apo-ACP into 
[1-14C]acetyl-holo-ACP using the 15 co/i ACPS 
To test whether the purified rat ape-ACP could be 
charged by the E. w/i ACPS (therefore still possessing a 
conformation recognized by the modifying enzyme). the 
A: 9661.91 
MW (Da) 
Calculated Observed 
Apo-ACP (-Met) 9686.07 9661.91 
Apo-ACP (+ Met) 9817.26 9812.63 
B: 9812.83 
Mass (Da) 
Electrospray mass spectrometry analysis of rat ACP(aa21 14-2202). 
ACP was incubated with [1-“Cjacetyl-CoA and a 3040%~ 
(NH,)ISO, fraction of E. co/i cell extract in which NQS had 
been overexpressed. A rat (I-‘-‘C ] I acet)-I-ACP was formed 
(Figure 8, lane 1) indicating that ACPS is capable of charg- 
ing purified rat ACP by transferring the [I-‘Y:]acet\;l- 
-I’-phosphopantetheine residue from [ 1-‘~C]acet);l-(:o,. 
‘I’he fact that rat ACP can be modified by I+:. m/i MIPS 
suggests that loss of functionalit\- during purification ~vas 
due to del-7hosI’hopantethein~l~~tion rather than loss of 
ACP conformation. 
To further optimize the transfer of the [l-‘4(:]acetyl- 
l’-l’hosphopantcthcinc residue onto the rat A<:P. highI>, 
purified E. di ACPS \vas used in the in Tit/-o reaction. A 
time course of the reaction showed saturation of ACPS 
after 30 minutes of incubation at 37°C: (data not shown), 
similar to the reaction with E. m/i AU’ [Ml. Rat ACP 
Figure 8 
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Lane 
Rat ACP 
ACPS 
Rat A-ACP - 
E. co/i A-ACP - 
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In vitro conversion of purified rat apo-ACP into [l -i4Clacetyl-holo-ACP 
upon incubation wrth E. co/i holo-ACP synthase (ACPS) and 
[l -r4C]acetyl-CoA. The reaction products were analyzed by 
autoradiography after separation on 200/o native PAGE and blottmg on 
PVDF membrane. (-), f. co/i extract added without ACPS expressed; 
(+), f. co/i extract added with the ACPS expressed; and A-ACP, 
[l -r4Clacetyl-ACP. The lower bands are probably degradatron 
products of [l -14C]acetyl-holo-ACP. 
concentrations (protein concentration based on Bradford 
[.51]) higher than 4-X phi inhibited the XCPS-catalyzed 
reaction. A similar substrate inhibition wxs also found for 
the I?. w/i ACP and the S’t~ptw~~y~s granaticin AU 
[29,39]. \Yhen 1 yhl rat ;jCP and 2.86 ph1 of tbc E. di 
ACPS prepuxtion u’ere LIX~, the molarit\- of labclcd 
product corresponded to the molarity of ACP used in the 
assay. which is consistent u,ith 100% con\wsion into the 
[1-‘l(:]acet!-I-ACI’ form. This reaction might pro\ ide ;I 
WI)- to spthcsize rat holo-ACP for further analysis of 
the structural and biochemical characteristics of the rat 
ACP(aa2113-2202) dom:iin. 
Significance 
Long-chain fat@ acids are synthesized in euhacteria and 
eukaryotes using fatty acid svnthase (FAS) complexes. 
Type II FASs, as found in bacteria, are composed of a 
set of monofunctional proteins, whereas the eukaryotic 
Type I FAS is a single polypeptide that contains several 
catalytic functions. We have defined an acyl carrier 
protein (ACP) domain of the multifunctional Type I rat 
FAS, which can be expressed as a soluble protein, for 
investigation of its capacity to replace Type II ACPs of 
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fatt\- acid and polyketide synthases (PIiS). Expression 
in Escherichin coli resulted in a small percentage of post- 
translationally modified holo-ACP, increasing fivefold 
upon co-expression with the E. coli FAS-specific holo- 
ACP synthase (ACPS). The rat ACP was capable of 
interacting with some components of the E. coli FAS, 
namely MCAT, KS I and the reductases, to form (at 
least) butvryl-ACP. It was further shown to function- 
ally replace - though with low efficiency - a Type II 
ACP from the more distantly related and more diverse 
enzyme system, the actinorhodin PKS of Streptovzyces 
coelicolw. The results suggest that the recombinant rat 
ACP domain can fold into a conformation similar to the 
E. coli FAS ACP and the S. roelicolor actinorhodin PKS 
ACP. Our results provide some support for the hypothe- 
sis that Type I FAS evolved from the Type II mono- 
functional system b?- fusion of the corresponding Type 
II genes. We also describe a three-step purification pro- 
cedure that resulted in the isolation of inactive rat apo- 
ACP. The purified rat apo-ACP was activated b, 
overexpressed E. cmli ACPS using [l-‘%lacetyl-4’-phos- 
phopantetheine Z’U z+tw. IJsing purified ACPS fraction 
in the in zx’tro reaction resulted in 100% conversion of 
the rat ACP into the acetyl-ACP form, which might 
provide a way to synthesize sufficient rat ACP for 
further structural and biochemical investigations. 
Materials and methods 
Bacterial strains and plasmids 
E. co/i DH5n (supE44 AlacUl69 (Q80lacZAM15) hsdR17 recA1 
endA gyrA96 thr-1 relA1) was used as the standard cloning host [521. 
Expression of proteins from T7-controlled PET vectors was performed 
in E. co/i BL21 (DE3) (F- ompT hsdS gal rs- ms-) [53]. The T7-based 
expression vector pETl5b was obtained from Novagen. The full-length 
rat FAS plasmid pcRFAS6OlC was described by Kupfer et al. [54]. 
The plasmid containrng the f. co/i acpS gene was described previously 
1381. E. co/i BL21 (DE3)IpDPJ was described by Lambalot and Walsh 
[291. E. co/i ET12567 (dam- dcm- hsdM-) was used to isolate 
unmethylated DNA [55]. S. coelicolor A3(2)CH999 (proA argA1 
SCPI- SCP2- redEGO Aact) and plasmid pRM5, directing the expres- 
sion of the actinorhodin minimal PKS and associated subunits, are 
described by McDaniel et al. [491. Standard conditions for culture of 
Streptomyces were as described by Hopwood et al. 1561. 
General DNA techniques 
Recombinant DNA techniques using E. co/i were performed as 
described previously [57]. Plasmid DNA was prepared according to 
Jones and Schofield [581. DNA techniques using S. coellcolor were 
performed as described previously [56]. DNA for sequencing was pre- 
pared using Cliagen plasmid purification columns (QIAGEN) according 
to the manufacturer’s recommendatrons. Ampli TaqR (Perkin Elmer) 
was used in PCR according to the manufacturer’s recommendations. 
Sequencing reactions were carried out using the Applied Biosystems 
cycle sequencing PRISM mix with Taq FS enzyme rn an Applied 
Biosystems 373 sequencing machine. 
General protein techniques 
Proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) [591 using a Mini-Protean II System 
(Bra-Rad). Native PAGE using 20% (w/v) total acrylamide with bis- 
acrylamide at 1.0% of the final volume was performed as described 
prevrously [501. Conformationally sensitive PAGE in the presence of 
urea was performed accordrng to Post-Beitenmiller et al. [44]. Proteins 
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were visualized by staining with SERVA Blue R (SERVA, Germany), 
Low range protein standards were obtained from Sigma. Protein con- 
centrations were measured according to Bradford [51]. Amino-terminal 
amino acid sequence of the ACP was obtained after partial purification, 
separation on a 15% (w/v) SDS-PAGE and transfer onto ProBlott 
membrane (Applied Biosystems). Purified proteins were analyzed by 
electrospray mass spectrometry (ESMS) as described previously [37]. 
Construction of expression clones encoding the rat ACP 
domain 
The ACP domain was amplified by PCR using pcRFAS601 C [54] as a 
template. Primers used for the construction of pET1 Sb-ACP(aa2131- 
2194) were: (1) 5’-primer: 5’-CCCATGAGCTCTGTACCATGGGCA- 
TCCGCGACCTCGCAGG-3’; (2) 3’.primer: 5’-TTGGATCCTTACTC- 
AGTGTCTGAGCCAGCCTTGG-3’. For the construction of pETl5b- 
ACP(aa2114-2202) the following primers were used: (3) 5’-primer: 
5’.GCTGTGGCCATGGGTGACGGTGAAGCTCAGCGTGATCTGG-3’; 
(4) 3’.primer: 5’.GGCCTGCTTCAGGGATCCTTAATTCTTGGACTTGGACTT- 
GGGGGC-3’ (nucleotides deviating from the original gene sequence 
are italicized). The 5’-primers introduced an ATG codon as well as a 
Ncol restriction site. The 3’-primer introduced a stop codon as well as 
a BamHl site. In clone pETlSb-ACP(aa21 14-2202) the first seven 
codons were changed to synonymous codons present in highly 
expressed f. co/i genes [34]. The PCR used the following cycles: 
1 x 5 min 94°C 30 x (2 min 60°C, 1 min 72°C 1 min 94”(Z), 1 x (2 min 
60°C 7 min 72°C). PCR products were digested with Ncol and 
BamHl prior to cloning into pETl5b. Sequencing was performed with 
the PET forward and reverse primers. 
For co-expression of the rat ACP with the E. co/i acpS gene the 
plasmid pETl5b-ACP(aa2114-2202) was digested with BamHl and 
the Bglll fraglment from the plasmid containing the acpS gene [38] was 
introduced’to create pETl5b-ACP(aa2114-2202)-acpS. Expression 
of the rat A’CP was performed in E. co/i BL21 (DE3) as described previ- 
ously [53]. Expression was performed at 37°C for 4 h unless otherwise 
stated. Because of plasmid instability, the co-expression plasmid, 
pETl5b-ACP(aa2114-2202)-acpS, was grown from freshly trans- 
formed E. co/i BL21 (DE3) colonies until slightly turbid. Several glycerol 
stocks were kept at -80°C and directly used to inoculate LB broth with 
ampicillin for inductions. 
Malonyl-CoA:ACP transacylase (MCA T) assay 
Induced f. co/i cell pellets were washed with 50 mM potassium phos- 
phate pH 7.2, 0.5 M  NaCI, followed by a wash with 50 mM potassium 
phosphate pH 7.2. Cell pellets from 10 ml culture were resuspended 
in 50 mM potassium phosphate pH 7.2, 100/o glycerol, 2 mM dithio- 
threitol (DTT) and broken by sonication in a Soniprep 150 (MSE) at 
50% power for four cycles of 6 s. The supernatant fraction was col- 
lected by centrifugation and dialysed overnight against 50 mM potas- 
sium phosphate pH 7.2, 10% glycerol, 2 mM DTT at 4%. Protein 
extracts from S. coelicolor CH999 mycelium were obtained by sonica- 
tion for six cycles of 10 s after growth on solid medium until pigment 
production was visible for CH999IpRM5. The MCAT assays were 
modified from Crosby et a/. [37]; 5-l 0 ug of total cell protein and 
0.86 nmol [2-r4C]malonyl-CoA (2.2 GBq/mmol; DuPont NEN) were 
used. The assay was analyzed by autoradiography, after separating 
the reaction mixture on a 20% native PAGE and transferring onto a 
0.2 urn pore-size polyvinylidene difluoride (PVDF) membrane (Trans- 
Blot, Bio-Rad), using a type BASIlIs imaging plate and BAS 1000 
Bioimaging analyzer (Fuji). 
Acetoacetyl-ACP synthase assay 
E. co/i BL21 (DES)/pETl5b-ACP(aa2114-2202)-acpS was grown 
and induced as described above. The washed cells were broken by 
sonication, and a 40-70% (NH,),SO, cut was prepared (fraction A, 
which contains both the acetoacetyl-ACP synthase [22] and the rat 
ACP). Precipitated proteins were stored in aliquots at -80°C and 
desalted on a Sephadex G25 column prior to use. The reaction was 
performed in a final volume of 20 ul modified according to the method 
described by Jackowski et al. [46] with 20 mM potassium phosphate 
pH 7.2, 2 mM DTT, 50 kg/ml cerulenin (in ethanol), 1 mM NADH, 1 mM 
NADPH, 125 ,trM malonyl-CoA (for 14C-labeled substrate with 
20 Bq/nmole), 150 uM acetyl-CoA (for 14C-labeled substrate with 
154 Bq/nmole) and 50-80 ug of total protein. The reaction was started 
by addition of the 14C-labeled substrate after preincubation for 10 min 
at room temperature and further incubation for 10 min at 37°C. The 
assay was analyzed by 15% (w/v) conformationally sensitive PAGE in 
the presence of 0.5 M  urea, followed by blotting to PVDF membrane 
and autoradiography as described for the MCAT assay. 
Acyl-ACP synthetase assay 
The assay was performed using a 40-700/o (NH&SO, cut prepared 
as described for the acetoacetyl-ACP synthase assay. The assay con- 
ditions were as described by Rock and Cronan [48] using 2.4 kBq [l- 
14C] palmitic acid (1.2 nmol; DuPont, NEN) per assay and adding 
O-O.3 mU acyl-ACP synthetase (Sigma) per assay. The reaction 
mixture was analyzed by 15% (w/v) conformationally sensitive PAGE in 
the presence of 2.5 M  urea, followed by transfer to PVDF membrane 
and autoradiography. 
Construction of the hybrid rat FAS ACP domain/act PKS 
expression system and its expression in S. coelicolor 
The ACP(aa2114-2202) domain was amplified by PCR using 
pcRFAS6OlC [54] as the template. The 5’.primer was designed to 
introduce (in order): an Xbal site, a Sfrepfomyces ribosome-binding 
site, an ATG start codon, and the first eight codons changed to syn- 
onymous codons but which are present in highly expressed genes in 
Streptomyces spp. [60]. The sequences were as follows: 5’-ATAG- 
GTCTAGAACTGGAGAAAGCCATGCACGGCGACGGCGAGGC- 
CCAGAGGGAT-3’. The 3’.primer was designed to introduce a stop 
codon and a Psfl site as follows: 5’-GCTGGGCCTGCTGCAGGGAT- 
GTTCAATTCTTGGAGTTGG-3’ (bases deviating from the original 
sequences are italicized). The PCR cycles were: 1 x 5 min 94°C 
30x (2 min 60°C 1 min 72°C 1 min 94’C), 1 x (2 min 60°C, 7 min 
72’C). The PCR product was digested with Xbal and Psfl and cloned 
in pBluescriptSK(+). DNA sequencing confirmed that the amplified 
gene had the expected sequence. The XballPstl rat ACP fragment was 
cloned in place of the act ACP gene in plJ5639 [611 to create 
plJ5639-rat ACP. The XballEcoRI fragment was isolated and cloned 
into pRM5 (in place of the original XballEcoRI fragment; carrying the 
set of act PKS and cyclase genes) to create pRM5-rat ACP (now act 
PKS in which act ACP is replaced by rat ACP). For construction of a 
rat ACP, in which the attachment site for the prosthetic group is 
mutated from a serine to an alanine residue, the ‘Quick ChangeTM Site- 
Directed Mutagenesis Kit’ (Stratagene) was used according to the 
manufacturer’s recommendations with the following oligonucleotides: 
5’.CCTCGGCCTGGACGCGCTCATGGGTGTG-3’ and 5’CACAC 
CCATGAGCGCGTCCAGGCCGAGG-3’. Prior to introduction into 
S. coelicolor CH999 (the Aacf PKS expression host), the plasmid was 
passaged through E. co/i ET1 2567. 
Extraction of pigment from S. coelicolor CH999 colonies 
Aloesaponarin II was isolated according to Bartel et a/. [62] and ana- 
lyzed on a thin layer chromatography (TLC) plate with co-migration of 
standard aloesaponarin II on silica gel TLC plates (Merck) in ethyl 
acetate/l O/o HCI. 
Purification of recombinant ACP(aa2174-2202) 
Cells from 500 ml culture of BL21 (DE3)/pETl Sb-ACP(aa21 14- 
2202)-acpS were harvested and washed with 20 mM Tris-HCI pH 7.4, 
0.5 M  NaCI, followed by a washing with 20 mM Tris-HCI pH 7.4. For 
extraction of proteins, the freeze-thaw method described by Johnson 
and Hecht [63] was used with 20 mM Tris-HCI pH 7.4, 2 mM DTT as 
extraction buffer. DNA from the clear supernatant was precipitated by 
adding ice-cold 10% streptomycin sulfate to a final concentration of 
1 o/,, further stirred for 1 h in ice water and centrifuged. The clear super- 
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natant was loaded on a 20% (w/v) preparative native PAGE (Prep Cell- 
491; Bio-Rad) as described by Revill et al. 1641. Proteins were eluted 
using 20 mM Tris-HCI pH 7.4. Fractions containing the rat ACP were 
pooled and separated from contaminating E. co/i proteins by anion- 
exchange chromatography (Mono Q HR5/5; Pharmacia). The ACP was 
eluted at 0.5 M  KCI in a linear salt gradient of O-l M  KCI. Purification 
was monitored using 15% SDS-PAGE and the MCAT assay. Alterna- 
tively, for the in vitro reaction with E. co/i ACPS, rat ACP was purified 
by freeze-thaw extraction, ultracentrifugation (60 minutes, 100,000 
rpm, 4”C), streptomycin sulfate precipitation and anion-exchange-per- 
fusion chromatography (Ha). This procedure resulted in about 95% 
pure rat ACP. 
Holo-ACP synthase (ACPS) assay 
E. co/i ACPS was expressed from pDPJ in E. co/i BL21 (DE3) as 
described previously [29]. A 30-600/o (NH,),SO, cut of the crude 
extract or purified ACPS (purification as described recently [29]) was 
used in the ACPS assay, performed according to Cox et a/. [38] except 
that reactions were performed in a final volume of 20 ul with 200 uM 
[l -14C]acetyl-CoA (74 Bqlnmole). The assays were analyzed either by 
autoradiography as in the MCAT assay or by tricholoroacetic acid pre- 
cipitation as described previously [37]. 
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